Artiva Biotherapeutics, Inc. (ARTV)
5.80
-0.52
(-8.23%)
USD |
NASDAQ |
Mar 18, 16:00
5.77
-0.03
(-0.52%)
After-Hours: 20:00
Artiva Biotherapeutics Total Liabilities (Quarterly) : 24.60M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Rocket Pharmaceuticals, Inc. | 53.23M |
| Merck & Co., Inc. | 84.20B |
| Regeneron Pharmaceuticals, Inc. | 9.302B |
| Innoviva, Inc. | 462.32M |
| ACADIA Pharmaceuticals, Inc. | 336.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 134.57M |
| Shareholders Equity (Quarterly) | 109.97M |
| Debt to Equity Ratio | 0.0995 |
| Current Ratio | 8.609 |
| Net Debt Paydown Yield | 0.76% |